These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12133898)

  • 1. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.
    Wagner N; Wagner KD; Schley G; Coupland SE; Heimann H; Grantyn R; Scholz H
    Cell Growth Differ; 2002 Jul; 13(7):297-305. PubMed ID: 12133898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.
    Caldon CE; Lee CS; Sutherland RL; Musgrove EA
    Oncogene; 2008 Jan; 27(1):126-38. PubMed ID: 17599043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells.
    Phelan SA; Lindberg C; Call KM
    Cell Growth Differ; 1994 Jun; 5(6):677-86. PubMed ID: 8086342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wilms' tumor gene Wt1 is required for normal development of the retina.
    Wagner KD; Wagner N; Vidal VP; Schley G; Wilhelm D; Schedl A; Englert C; Scholz H
    EMBO J; 2002 Mar; 21(6):1398-405. PubMed ID: 11889045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
    Sarfstein R; Werner H
    J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
    Glienke W; Maute L; Wicht J; Bergmann L
    Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
    Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
    Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
    Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
    Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
    Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
    Bellan C; De Falco G; Tosi GM; Lazzi S; Ferrari F; Morbini G; Bartolomei S; Toti P; Mangiavacchi P; Cevenini G; Trimarchi C; Cinti C; Giordano A; Leoncini L; Tosi P; Cottier H
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3602-8. PubMed ID: 12454024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
    Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
    Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parvalbumin, a horizontal cell-associated calcium-binding protein in retinoblastoma eyes.
    Kivelä T
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1044-8. PubMed ID: 9579485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
    Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
    Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
    Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
    Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
    Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
    Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
    Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.